Key result
In individuals with diabetic foot, serum 25(OH)D levels <50 nmol/L were associated with cardiac autonomic dysfunction (OR 0.56 per SD increase in 25(OH)D; 95% CI 0.44-0.72).
Why the study?
Vitamin D deficiency is linked to cardiac autonomic dysfunction and diabetic foot, but the impact of vitamin D levels on heart rate variability in individuals with diabetic foot remains unclear.
Are lower serum 25-hydroxyvitamin D levels associated with reduced heart rate variability and cardiac autonomic dysfunction in individuals with diabetic foot?
Cross-Sectional (n=458)
Are lower serum 25-hydroxyvitamin D levels associated with reduced heart rate variability and cardiac autonomic dysfunction in individuals with diabetic foot?
Odds Ratio: 0.56 (95% CI 0.44–0.72)
In individuals with diabetic foot, serum 25-hydroxyvitamin D levels below 50 nmol/L are significantly associated with an increased risk of cardiac autonomic dysfunction as measured by reduced heart rate variability.
Vitamin D-HRV association in diabetic foot is hypothesis-generating; leaves open whether supplementation improves autonomic function.
BACKGROUND: Previous studies have shown that vitamin D deficiency was associated with both cardiac autonomic dysfunction and the development of diabetic foot (DF). However, the impact of vitamin D levels on heart rate variability (HRV) in individuals with DF, a high-risk group, remains unclear. We explored the association between vitamin D status and HRV in individuals with DF. METHODS: A total of 458 individuals with DF were assessed for vitamin D levels by 25-hydroxyvitamin D (25(OH)D) and evaluated for cardiovascular autonomic function using both time and frequency domains of the HRV measures. Multivariate regression analysis and restricted cubic spline regression were employed to examine the associations. RESULTS: Vitamin D levels were positively associated with HRV indices in people with DF, including standard deviation of the normal sinus interval (SDNN), standard deviation of the 5-min average RR intervals (SDANN), low-frequency power (LF), high-frequency power (HF), and the LF/HF ratio (all p < 0.05). The associations between serum 25(OH)D and cardiac autonomic dysfunction were nonlinear. When 25(OH)D levels were < 50 nmol/L, the odds ratio (OR) for predicted cardiac autonomic dysfunction per SD increase in 25(OH)D was 0.56 (95% CI, 0.44-0.72). However, no significant effect was observed when 25(OH)D levels exceeded 50 nmol/L. CONCLUSIONS: This study demonstrates that lower 25(OH)D levels are associated with reduced HRV in individuals with DF. Specifically, when 25(OH)D levels fall below 50 nmol/L, the risk of cardiac autonomic dysfunction in people with DF significantly increases.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) conducted a cross-sectional in Diabetic foot (n=458). Serum 25-hydroxyvitamin D was evaluated on Cardiac autonomic dysfunction (OR 0.56, 95% CI 0.44-0.72). In individuals with diabetic foot, serum 25(OH)D levels <50 nmol/L were associated with cardiac autonomic dysfunction (OR 0.56 per SD increase in 25(OH)D; 95% CI 0.44-0.72).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: